Sector
PharmaceuticalsOpen
₹22.22Prev. Close
₹22.19Turnover(Lac.)
₹60.72Day's High
₹22.6Day's Low
₹21.8152 Week's High
₹56.552 Week's Low
₹20.02Book Value
₹48.41Face Value
₹1Mkt Cap (₹ Cr.)
490.68P/E
29.24EPS
0.76Divi. Yield
019 Aug 2024
12:00 AM
AGM
Announcement Date: 19 Aug, 2024
27 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
The facility was inspected primarily to assess its compliance with European Good Manufacturing Practices (EuGMP).
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 22.43 | 22.43 | 22.43 | 22.43 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,046.83 | 1,042.17 | 1,064.44 | 1,038.31 |
Net Worth | 1,069.26 | 1,064.6 | 1,086.87 | 1,060.74 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1,541.82 | 2,362.8 | 1,875.53 | 1,643.33 |
yoy growth (%) | -34.74 | 25.98 | 14.12 | -1.96 |
Raw materials | -1,155.61 | -1,857.58 | -1,366.48 | -1,154.16 |
As % of sales | 74.95 | 78.61 | 72.85 | 70.23 |
Employee costs | -73.37 | -80.99 | -78.4 | -79.23 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -59.33 | 35.74 | 62.56 | 67.21 |
Depreciation | -60.25 | -60.76 | -64.3 | -62.25 |
Tax paid | 11.5 | -5.68 | -10.41 | -12.07 |
Working capital | -198.01 | -62.6 | 154.59 | -9.65 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -34.74 | 25.98 | 14.12 | -1.96 |
Op profit growth | -49.92 | -7.65 | 5.27 | -6.12 |
EBIT growth | -67.38 | -9.11 | -3.71 | -1.38 |
Net profit growth | -343.32 | -42.36 | -5.4 | 1.47 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 1,925.83 | 1,746.56 | 1,925.52 | 1,763.74 | 2,642.86 |
Excise Duty | 241.75 | 222.89 | 256.69 | 220.44 | 276.48 |
Net Sales | 1,684.09 | 1,523.67 | 1,668.83 | 1,543.3 | 2,366.38 |
Other Operating Income | 1.55 | 0.94 | 0.03 | 1.07 | 0.36 |
Other Income | 13.03 | 42.24 | 11.29 | 2.72 | 4.01 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,675.7 | 93.94 | 4,02,320.49 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,809.5 | 81.86 | 1,80,822.6 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,505.9 | 25.26 | 1,21,584.26 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,408.2 | 60.56 | 1,15,394.56 | 474 | 0.94 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,283.3 | 20.03 | 1,07,135.26 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sanjiv Goyal
Nominee
Meena Verma
Independent Director
Rupinder Tewari
Independent Director
Kuldip Kumar Bhasin
Independent Director
Indu Pal Kaur
Director (Operation)
Puneet Sud
Village Saidpura,
Tehsil Derabassi S A S Nagar,
Punjab - 140507
Tel: 91-1762-308000
Website: http://www.neclife.com
Email: cs@neclife.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Nectar Lifescience Limited was incorporated on June 27, 1995 with the name Surya Medicare Limited. On March 26, 2004, Company changed their name from Surya Medicare Limited to Nectar Lifescience Limit...
Read More
Reports by Nectar Lifescience Ltd
What is the Nectar Lifescience Ltd share price today?
What is the Market Cap of Nectar Lifescience Ltd?
What is the PE and PB ratio of Nectar Lifescience Ltd?
What is the 52 Week High and Low of Nectar Lifescience Ltd?
What is the CAGR of Nectar Lifescience Ltd?
What is the shareholding pattern of Nectar Lifescience Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
